Aster DM Healthcare Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter

The Aster DM Healthcare Q2 results FY27 announcement is the next scheduled earnings event for Aster DM Quality Care Ltd., a hospital, clinic and pharmacy chain across India, renamed Aster DM Quality Care after absorbing the CARE Hospitals group. The stock traded at Rs 786.00 on the NSE on 9 September 2026, down 0.55% from the previous close of Rs 790.35, about 11.8% below its 52-week high of Rs 891.30 and 51.4% above its 52-week low of Rs 519.10.

What makes the Aster DM Healthcare Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 1,197.00 crore of revenue and a profit of Rs 121.00 crore, while the most recent quarter on record, Q1 FY27, produced Rs 1,311.00 crore and a profit of Rs 29.00 crore. Everything below is built from those reported figures rather than from any forecast.

Click Here – Get Free Investment Predictions

When Is the Aster DM Healthcare Q2 Results FY27 Date?

The Aster DM Healthcare Q2 results date for FY27 is not confirmed. As of 9 September 2026, Aster DM Quality Care Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.

What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Aster DM Healthcare Q2 results date becomes public through that filing rather than through any advance announcement.

The Aster DM Healthcare Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Aster DM Healthcare.

Aster DM Healthcare Q2 Results Expectations: What the Market Is Actually Tracking

No verified analyst estimate for the Aster DM Healthcare Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Aster DM Healthcare. The Aster DM Healthcare Q2 results watchlist below is built from what the company has actually reported and disclosed.

The first is the merger with Quality Care India, which took effect on 3 July 2026. Every quarter in the record above closed before that date, so the September 2026 quarter will report on a materially larger basis than any of them.

The second is that operating profit has been steady while reported profit has not. Operating profit ran Rs 202 crore to Rs 256 crore across the five quarters, and net profit ran Rs 29 crore to Rs 154 crore.

The third is what caused that gap. Q1 FY27 carried negative other income of Rs 77 crore and a 62% tax rate on the best operating quarter of the five, while March 2026 carried a 6% tax rate. Neither figure describes the hospitals.

Check Aster DM Quality Care Ltd. Live Fundamentals on the Univest Screener

Aster DM Healthcare Q2 Results Preview: The Q1 FY27 Actuals It Builds On

Aster DM Quality Care Ltd. reported revenue of Rs 1,311.00 crore in Q1 FY27, up 21.61% from Rs 1,078.00 crore in Q1 FY26, and a profit of Rs 29.00 crore at the net level, down 69.15% from Rs 94.00 crore in Q1 FY26. These are reported actuals, not estimates.

Sequentially, revenue was up 10.91% over the March 2026 quarter figure of Rs 1,182.00 crore, and net profit was down 81.17% from Rs 154.00 crore in Q4 FY26. Operating margin stood at 20% in Q1 FY27 against 20% in the September 2025 quarter, which is the comparison the Aster DM Healthcare Q2 results print will be read against.

Q2 FY26 Base: The Comparison Aster DM Healthcare Q2 Results FY27 Must Beat

Aster DM Quality Care Ltd. reported revenue of Rs 1,197.00 crore and a profit of Rs 121.00 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Aster DM Healthcare Q2 results preview.

Net profit in that base quarter was above the Rs 29.00 crore just reported for Q1 FY27, so the year-on-year comparison starts from a demanding level. Revenue of Rs 1,197.00 crore sits below the Rs 1,311.00 crore of the June 2026 quarter, which frames how much sequential movement the Aster DM Healthcare Q2 results print needs to show growth.

Aster DM Healthcare Quarterly Results Trend Over the Last Four Quarters

Quarter	Revenue (Rs Cr)	Net Profit (Rs Cr)
Q2 FY26 (Sep 2025)	1,197.00	121.00
Q3 FY26 (Dec 2025)	1,186.00	59.00
Q4 FY26 (Mar 2026)	1,182.00	154.00
Q1 FY27 (Jun 2026)	1,311.00	29.00

Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company's exchange filings, and they are the only basis this Aster DM Healthcare Q2 results preview uses.

Revenue across those four quarters ranged from Rs 1,182.00 crore to Rs 1,311.00 crore, and net profit from Rs 29.00 crore to Rs 154.00 crore. That spread is the honest context for the Aster DM Healthcare Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.

Key Factors That Could Shape Aster DM Healthcare Q2 Results FY27

The Aster DM Healthcare Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Aster DM Healthcare has already reported.

Comparisons Will Not Be Like for Like

Because the merger closed after the June quarter, a year-on-year revenue or profit comparison for the September quarter measures a larger group against a smaller one. Any growth percentage will overstate underlying performance.

Occupancy and Average Revenue Per Bed

Hospital profitability turns on how full the beds are and what each occupied bed earns, with case mix between high-value specialties and routine care setting the second. Both are disclosed in the operating metrics.

Volatility Sits Below the Operating Line

All the swing in reported profit came from other income and the tax charge rather than from operations. The price-to-earnings ratio of 190.03 rests on trailing earnings that those items depressed.

Aster DM Healthcare Q2 Results FY27: Share Price and Valuation Going Into the Print

Aster DM Healthcare share price today is Rs 786.00 on the NSE, down Rs 4.35 or 0.55% from the previous close of Rs 790.35 on 9 September 2026, ahead of the Aster DM Healthcare Q2 results announcement.

Metric	Value (9 September 2026)
NSE Symbol	ASTERDM
Current Market Price	Rs 786.00
52-Week High	Rs 891.30
52-Week Low	Rs 519.10
Market Capitalisation	Rs 68,578 crore
PE Ratio	190.03
PB Ratio	9.69
EPS (TTM)	Rs 4.14
Book Value per Share	Rs 81.10
Debt to Equity	0.62
Return on Equity	11.30%
50-Day Moving Average	Rs 801.61
200-Day Moving Average	Rs 700.43
RSI (14)	59.66

The stock trades below its 50-day average of Rs 801.61 but above its 200-day average of Rs 700.43, with a 14-day RSI of 59.66. None of this is a view on where the shares go once the Aster DM Healthcare Q2 results are announced, and no price target is offered here.

Download the Univest iOS App or Univest Android App to track Aster DM Quality Care Ltd. live price and quarterly earnings updates.

What Investors Should Watch When Aster DM Healthcare Q2 Results Are Announced

Four lines carry most of the information in a company of this size, and reading them in order keeps the Aster DM Healthcare Q2 results print in proportion.

1. Revenue against the Rs 1,197.00 crore reported in the September 2025 base quarter
2. Net profit against a profit of Rs 121.00 crore in that same quarter
3. Operating margin against 20% in Q1 FY27
4. Any exceptional item, provision or one-off gain disclosed alongside the numbers

A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Aster DM Healthcare Q2 results announcement should be read together with the notes to the results rather than the headline alone.

Conclusion on Aster DM Healthcare Q2 Results FY27

The Aster DM Healthcare Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Aster DM Quality Care Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.

On that basis the Aster DM Healthcare Q2 results FY27 print faces a base of Rs 1,197.00 crore in revenue and a profit of Rs 121.00 crore, with the most recent quarter having delivered Rs 1,311.00 crore and a profit of Rs 29.00 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Aster DM Healthcare, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.

FAQs on Aster DM Healthcare Q2 Results FY27

What is the Aster DM Healthcare Q2 results date for FY27?

Ans. The Aster DM Healthcare Q2 results date for FY27 is not confirmed. Aster DM Quality Care Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.

What quarter do the Aster DM Healthcare Q2 results 2026 cover?

Ans. The Aster DM Healthcare Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Aster DM Quality Care Ltd. reports revenue, operating profit and net profit for that period, and the Aster DM Healthcare Q2 results filing also carries the notes to the accounts.

What were the Aster DM Healthcare Q1 FY27 results?

Ans. Aster DM Quality Care Ltd. reported revenue of Rs 1,311.00 crore in Q1 FY27 and a profit of Rs 29.00 crore at the net level. Revenue was up 21.61% versus Q1 FY26 and net profit was down 69.15% from Rs 94.00 crore in Q1 FY26.

What were Aster DM Healthcare Q2 FY26 results in the September 2025 quarter?

Ans. Aster DM Quality Care Ltd. reported revenue of Rs 1,197.00 crore and a profit of Rs 121.00 crore in Q2 FY26. Operating margin was 20%. Those figures form the base for the Aster DM Healthcare Q2 results FY27 comparison.

What are the main Aster DM Healthcare Q2 results expectations this quarter?

Ans. No verified analyst estimate is publicly available. The Aster DM Healthcare Q2 results expectations centre on revenue against the Rs 1,197.00 crore base, net profit against a profit of Rs 121.00 crore, operating margin against 20% in Q1 FY27, and any exceptional item disclosed with the numbers.

What is Aster DM Healthcare share price today ahead of the Q2 earnings?

Ans. Aster DM Healthcare share price is Rs 786.00 on the NSE as of 9 September 2026, down 0.55% from Rs 790.35. The stock is about 11.8% below its 52-week high of Rs 891.30 and 51.4% above its 52-week low of Rs 519.10, at a market capitalisation of Rs 68,578 crore.

Is Aster DM Healthcare a good stock to buy before the Q2 results?

Ans. This article does not offer a buy, sell or hold recommendation on Aster DM Quality Care Ltd.. The stock trades at a price-to-book ratio of 9.69 with a return on equity of 11.30%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.